Orca Bio rallies $192m Series D
Menlo Park, California-based Orca Bio, a developer of high precision allogeneic cell therapies, has raised $192 million in Series D financing.
Menlo Park, California-based Orca Bio, a developer of high precision allogeneic cell therapies, has raised $192 million in Series D financing.
Copyright PEI Media
Not for publication, email or dissemination